Yuge Ji Profile
Yuge Ji

@_yji_

Followers
220
Following
200
Media
9
Statuses
70

ML in compbio, scanlating~

Cambridge, MA
Joined February 2016
Don't wanna be here? Send us removal request.
@_yji_
Yuge Ji
1 year
Do you run functional assays? Wish you could get more results without having to scale?. If you’re not using Prophet, you’re leaving potential on the table. (Warning: pitch not tweetorial).
1
13
34
@_yji_
Yuge Ji
2 months
I went to #BIOInternational this year and wished I'd gone 10 years ago. This is my attempt at convincing any early career researcher(or otherwise) to go for this unsupervised data collection experience. #BIO2025
Tweet media one
0
0
3
@_yji_
Yuge Ji
5 months
RT @nalidoust: Meet the judges & mentors for the Tahoe Deep Dive Hackathon & thanks @awscloud for offering the prize: $25K AWS credits to w….
0
12
0
@_yji_
Yuge Ji
7 months
RT @pkoo562: [SAVE THE DATE] MLCB 2025 is happening Sep 10-11 at the NY Genome Center—NYC!. Attend the premier conference at the intersecti….
0
42
0
@_yji_
Yuge Ji
8 months
And no, I cannot.
0
0
0
@_yji_
Yuge Ji
8 months
Hot take: if you work in AI for medicine you should be able to pass Step 1.
1
0
1
@_yji_
Yuge Ji
8 months
I know the problem lies with how publishing incentives work but I wish there were a way to repair trust, even despite the current publishing system.
1
0
0
@_yji_
Yuge Ji
8 months
Pfizer (the authors here) is the end user, they shouldn't be the ones having to call out papers from @NatureBiotech . What is the point of academic research if the hurdle of "trusting it enough to try it" gets so big no one uses academic methods at all?.
1
1
2
@_yji_
Yuge Ji
8 months
Grateful to see industry putting out thoughtful benchmarking work like this but sad to imagine what they must think about academia and bio ML papers.
Tweet card summary image
biorxiv.org
Modeling genetic perturbations and their effect on the transcriptome is a key area of pharmaceutical research. Due to the complexity of the transcriptome, there has been much excitement and develop...
1
1
4
@_yji_
Yuge Ji
9 months
RT @SikkemaLisa: 1/7 Planning to build a single-cell atlas? Or wondering how atlases can be useful to your research? Read our guide on sing….
0
17
0
@_yji_
Yuge Ji
10 months
And probably add a few years to your lifespan on top of everything else (come through longevity twitter).
0
0
1
@_yji_
Yuge Ji
10 months
(If you have kids, they’ll be multilingual!).
0
0
0
@_yji_
Yuge Ji
10 months
Live there for a few years, return fashionable AND polite.
0
0
0
@_yji_
Yuge Ji
10 months
All you have to do is learn a little bit of Japanese.
0
0
0
@_yji_
Yuge Ji
10 months
Guys let’s move to Japan.
4
0
4
@_yji_
Yuge Ji
11 months
RT @aaron_wtr: 11/14 Looking ahead, we believe progress in this field will specifically require two key elements:.- Higher-quality data spa….
0
1
0
@_yji_
Yuge Ji
11 months
First (public) blog post - on single-cell, bubbles, and discovery
Tweet media one
0
1
4
@_yji_
Yuge Ji
11 months
My silver lining is that maybe this means more funding goes to high quality data generating institutions and technologies, the only reason we have AI in the first place.
0
0
4
@_yji_
Yuge Ji
1 year
RT @xuanalogue: *foists upon the gf my unused EA t-shirt so she can use it as pyjamas*. me: see I'm so effective! the marginal benefit-to-c….
0
2
0
@_yji_
Yuge Ji
1 year
(Admittedly this objection has more to do with IND policy, but still).
0
0
0
@_yji_
Yuge Ji
1 year
You might think @jacobkimmel makes some obvious statements here, but the de facto approach is still target-based drug discovery :( . Phenotypic drug discovery when.
@jacobkimmel
Jacob Kimmel
1 year
a distinct disipline is emerging from the bio & ML intersection -- predictive biology. - enabled by AI.- understanding = prediction, not causal diagrams.- emergent instead of reductionist.- new institutions: industrial > academic. a rough attempt at outlining the new field:
Tweet media one
1
0
2